Xiao Qu
301 Yanchang Road
Shanghai, 200072, China
Shanghai, 200072, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 20 publications
Enabling Targeted Drug Delivery for Treatment of Ulcerative Colitis with Mucosal-Adhesive Photoreactive Hydrogel.
Journal: Advanced science (Weinheim, Baden-Wurttemberg, Germany)
Published: May 05, 2024
Modulation of Intratumoral Fusobacterium nucleatum to Enhance Sonodynamic Therapy for Colorectal Cancer with Reduced Phototoxic Skin Injury.
Journal: ACS nano
Published: May 18, 2023
Enzyme-catalyzed synthesis of selenium-doped manganese phosphate for synergistic therapy of drug-resistant colorectal cancer.
Journal: Journal of nanobiotechnology
Published: October 24, 2022
Topoisomerase IIβ binding protein 1 serves as a novel prognostic biomarker for stage II-III colorectal cancer patients.
Journal: Pathology, research and practice
Published: September 21, 2022
Nodal promotes colorectal cancer survival and metastasis through regulating SCD1-mediated ferroptosis resistance.
Journal: Cell death & disease
Published: September 17, 2022
Targeting inorganic nanoparticles to tumors using biological membrane-coated technology.
Journal: MedComm
Published: September 16, 2022
Novel evidence for the prognostic impact of β-blockers in solid cancer patients receiving immune checkpoint inhibitors.
Journal: International immunopharmacology
Published: June 16, 2022
Identification of a novel prognostic signature correlated with epithelial-mesenchymal transition, N6-methyladenosine modification, and immune infiltration in colorectal cancer.
Journal: Cancer medicine
Published: May 20, 2022
Efficacy, safety, and biomarker analysis of Camrelizumab in Previously Treated Recurrent or Metastatic Nasopharyngeal Carcinoma (CAPTAIN study).
Journal: Journal for immunotherapy of cancer
Published: November 16, 2021
Fusobacterium Nucleatum Promotes the Development of Colorectal Cancer by Activating a Cytochrome P450/Epoxyoctadecenoic Acid Axis via TLR4/Keap1/NRF2 Signaling.
Journal: Cancer research
Published: February 08, 2021
Last Updated: 09/26/2026